Loading clinical trials...
Loading clinical trials...
A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node
Conditions
Interventions
Completion Lymphadenectomy
Monitoring with nodal ultrasound
Locations
63
United States
Sharp Hospital
San Diego, California, United States
John Wayne Cancer Institute
Santa Monica, California, United States
Memorial Hospital - Colorado Springs
Colorado Springs, Colorado, United States
Lakeland Regional Cancer Center
Lakeland, Florida, United States
H. Lee Moffitt Cancer Center
Tampa, Florida, United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Start Date
September 30, 2004
Primary Completion Date
September 30, 2019
Completion Date
September 30, 2019
Last Updated
May 13, 2022
NCT03340506
NCT05969860
NCT04693377
NCT05111574
NCT06500455
NCT06066138
Lead Sponsor
Saint John's Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions